Kwan Ho Tang

3.8k total citations · 1 hit paper
20 papers, 2.4k citations indexed

About

Kwan Ho Tang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kwan Ho Tang has authored 20 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kwan Ho Tang's work include Cancer Cells and Metastasis (4 papers), Cancer Research and Treatments (3 papers) and Protein Tyrosine Phosphatases (3 papers). Kwan Ho Tang is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Cancer Research and Treatments (3 papers) and Protein Tyrosine Phosphatases (3 papers). Kwan Ho Tang collaborates with scholars based in Hong Kong, China and United States. Kwan Ho Tang's co-authors include Stephanie Ma, Terence K. Lee, Irene Oi‐Lin Ng, Antonia Castilho, Xin‐Yuan Guan, Kwok Wah Chan, Man Tong, Bo‐Jian Zheng, Pak Shing Kwan and Yuen Piu Chan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Kwan Ho Tang

19 papers receiving 2.4k citations

Hit Papers

CD24+ Liver Tumor-Initiat... 2011 2026 2016 2021 2011 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kwan Ho Tang Hong Kong 14 1.5k 1.3k 870 387 330 20 2.4k
Eunice Y. Lau Hong Kong 20 1.1k 0.7× 624 0.5× 755 0.9× 397 1.0× 254 0.8× 37 2.0k
Laia Caja Sweden 23 1.1k 0.7× 744 0.6× 434 0.5× 347 0.9× 281 0.9× 39 1.9k
Juanjuan Shan China 24 1.4k 0.9× 635 0.5× 735 0.8× 208 0.5× 191 0.6× 41 2.1k
Kwan Man Hong Kong 17 1.7k 1.1× 743 0.6× 1.3k 1.4× 226 0.6× 402 1.2× 24 2.5k
David Kung‐Chun Chiu Hong Kong 21 2.2k 1.5× 743 0.6× 1.4k 1.6× 655 1.7× 169 0.5× 36 3.3k
Ray Somcio United States 17 1.3k 0.8× 1.0k 0.8× 671 0.8× 147 0.4× 208 0.6× 23 2.0k
Nila U. Parikh United States 26 1.5k 1.0× 1.2k 1.0× 522 0.6× 211 0.5× 141 0.4× 39 2.5k
Tijana Borovski Netherlands 11 1.5k 1.0× 1.5k 1.2× 777 0.9× 202 0.5× 90 0.3× 12 2.5k
Peng–Yuan Zhuang China 16 700 0.5× 706 0.5× 491 0.6× 596 1.5× 501 1.5× 28 1.8k
Randall Schreck United States 9 1.5k 1.0× 686 0.5× 469 0.5× 167 0.4× 298 0.9× 13 2.3k

Countries citing papers authored by Kwan Ho Tang

Since Specialization
Citations

This map shows the geographic impact of Kwan Ho Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kwan Ho Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kwan Ho Tang more than expected).

Fields of papers citing papers by Kwan Ho Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kwan Ho Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kwan Ho Tang. The network helps show where Kwan Ho Tang may publish in the future.

Co-authorship network of co-authors of Kwan Ho Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Kwan Ho Tang. A scholar is included among the top collaborators of Kwan Ho Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kwan Ho Tang. Kwan Ho Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Sait, Sameer Farouk, Kwan Ho Tang, Steven P. Angus, et al.. (2024). Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors. Proceedings of the National Academy of Sciences. 122(1). e2407745121–e2407745121. 2 indexed citations
4.
Wu, Chih‐Hung, et al.. (2024). The effects of matching/mismatching cognitive styles in E-learning. Educational Psychology. 44(9-10). 1048–1072. 1 indexed citations
5.
Hussain, Ali, Véronique Voisin, Stephanie Poon, et al.. (2020). Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21. The Journal of Experimental Medicine. 217(8). 64 indexed citations
6.
Leung, Carmen Oi Ning, Man Tong, Noélia Che, et al.. (2019). Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma. Hepatology. 72(1). 155–168. 73 indexed citations
7.
Sinha, Ankit, Ali Hussain, Vladimir Ignatchenko, et al.. (2019). N-Glycoproteomics of Patient-Derived Xenografts: A Strategy to Discover Tumor-Associated Proteins in High-Grade Serous Ovarian Cancer. Cell Systems. 8(4). 345–351.e4. 26 indexed citations
8.
Fedele, Carmine, Hao Ran, Brian Diskin, et al.. (2018). SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models. Cancer Discovery. 8(10). 1237–1249. 210 indexed citations
9.
Lee, Terence K., Ping Lu, Eunice Y. Lau, et al.. (2014). Blockade of Cd47-Mediated Cathepsin S/Protease-Activated Receptor 2 Signaling Provides a Therapeutic Target for Hepatocellular Carcinoma. Hepatology. 60(1). 179–191. 183 indexed citations
10.
Tang, Kwan Ho, et al.. (2014). 89 Tie-2 regulates the stemness of prostate cancer cells. European Journal of Cancer. 50. 33–33. 1 indexed citations
11.
Tang, Kwan Ho, Yong Dai, Man Tong, et al.. (2013). A CD90+ Tumor-Initiating Cell Population with an Aggressive Signature and Metastatic Capacity in Esophageal Cancer. Cancer Research. 73(7). 2322–2332. 128 indexed citations
12.
Tong, Man, Kwok Wah Chan, Jessie Y.J. Bao, et al.. (2012). Rab25 Is a Tumor Suppressor Gene with Antiangiogenic and Anti-Invasive Activities in Esophageal Squamous Cell Carcinoma. Cancer Research. 72(22). 6024–6035. 96 indexed citations
13.
Ma, Stephanie, Yuen Piu Chan, Pak Shing Kwan, et al.. (2011). MicroRNA-616 Induces Androgen-Independent Growth of Prostate Cancer Cells by Suppressing Expression of Tissue Factor Pathway Inhibitor TFPI-2. Cancer Research. 71(2). 583–592. 5 indexed citations
14.
Lee, Terence K., et al.. (2011). CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation. Cell stem cell. 9(1). 50–63. 502 indexed citations breakdown →
15.
Tang, Kwan Ho, Stephanie Ma, Terence K. Lee, et al.. (2011). CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Hepatology. 55(3). 807–820. 206 indexed citations
16.
Ma, Stephanie, Kwan Ho Tang, Yuen Piu Chan, et al.. (2010). miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1. Cell stem cell. 7(6). 694–707. 328 indexed citations
17.
Chen, Leilei, Tim Hon Man Chan, Yunfei Yuan, et al.. (2010). CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. Journal of Clinical Investigation. 120(4). 1178–1191. 119 indexed citations
18.
Lee, Terence K., et al.. (2010). Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation. Hepatology. 53(1). 160–170. 91 indexed citations
19.
Chan, Yuen Piu, Chee Wai Chua, Cian M. McCrudden, et al.. (2009). Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1. British Journal of Cancer. 102(2). 332–341. 19 indexed citations
20.
Ma, Stephanie, Kwok Wah Chan, Terence K. Lee, et al.. (2008). Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations. Molecular Cancer Research. 6(7). 1146–1153. 383 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026